ETC
-
Adacel
- Ingredient
noninfectious tetanus, diphtheria, and pertussis proteins, aluminum
phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde.
- Content
- Indication
active booster immunization against
tetanus, diphtheria and pertussis. Adacel is approved for use in persons 10
through 64 years of age.
-
Aggrastat Inj.
- Ingredient
Tirofiban Hydrochloride Hydrate
- Content
14.05mg/50ml (12.5mg/50ml as tirofiban)
- Indication
Co-administration with heparin in the patients who are:
– target patients in the treatment of acute coronary syndrome (ACS)
– patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomyIt has been shown to reduce the incidence of death, myocardial infarction, or combined endpoints of refractory ischemia/recardiac procedures.
-
Allegra Tab. 180mg
- Ingredient
Fexofenadine Hydrochloride
- Content
180mg
- Indication
Relief of symptoms associated with allergic skin disease (chronic idiopathic urticaria).
-
Allegra Tab. 30mg
- Ingredient
Fexofenadine Hydrochloride
- Content
30mg
- Indication
Relief of symptoms associated with seasonal allergic rhinitis and allergic skin diseases (chronic idiopathic urticaria)
-
Allegra-D
- Ingredient
Fexofenadine Hydrochloride 60mg
Pseudoephedrine Hydrochloride 120mg
- Content
Fexofenadine Hydrochloride 60mg
Pseudoephedrine Hydrochloride 120mg
- Indication
1. Relief of the following symptoms due to seasonal allergic rhinitis: sneezing, runny nose, itchy nose, mouth, throat, itching eyes, lacrimation, hyperemia, nasal congestion
2. Use this drug when both the antihistamine effect of fexofenadine hydrochloride and the decongestant effect of pseudoephedrine hydrochloride are required.
-
Amaryl M Tab.
- Ingredient
Glimepiride/Metformin Hydrochloride
- Content
1/250mg, 1/500mg, 2/500mg
- Indication
This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.
-
Amaryl Mex SR Tab.
- Ingredient
Glimepiride/Metformin Hydrochloride
- Content
2mg/500mg
- Indication
This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes who are adequate to combination therapy of glimepiride and metformin.
-
Amaryl Tab.
- Ingredient
Glimepiride
- Content
1mg, 2mg, 4mg
- Indication
This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes.
– Monotherapy
– Combination therapy
-
Arixtra Inj.
- Ingredient
Fondaparinux Sodium
- Content
2.5mg/0.5ml (pre-filled syringe)
- Indication
1) Prophylaxis of venous thromboembolism in patients undergoing major orthopedic surgery of the lower limb, such as hip fracture surgery, knee surgery, or hip replacement surgery
2) Prophylaxis of venous thromboembolism in patients underwent abdominal surgery, such as abdominal cancer surgery who are deemed to have a high risk of thromboembolic complications
3) Prophylaxis of venous thromboembolism in patients with limited mobility due to acute diseases such as heart failure (NYHA class Ⅲ or Ⅳ), acute respiratory disease, acute infection or inflammatory disease and medical patients who are deemed to have a high risk of venous thromboembolism
4) Treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) in patients who are not covered by emergency invasive management (Percutaneous Coronary Intervention(PCI) within 120 minutes)
5) Treatment of ST segment elevation myocardial infarction (STEMI) in patients who are being treated with thrombolytic agents or initially not receiving other forms of reperfusion therapy
-
AVAXIM 160U ADULT INJ.
- Ingredient
Hepatitis A virus, GBM strain (inactivated)1, 2……160 EU
- Content
- Indication
active immunisation against hepatitis A infection in adults and
children 2 years and over